David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
CALL
NOV
NOV
$7.21B
| $1.15M | ﹤0.01% |
+43,000
| New | +$1.22M |
|
|
AUD
2477
DELISTED
Audacy, Inc.
AUD
| $1.15M | ﹤0.01% |
218,377
-159,846
| -42% | -$1.06M |
|
2478
United Microelectronic
UMC
$47.7B
| $1.14M | ﹤0.01% |
608,160
+54,734
| +10% | +$101K |
|
2479
Monarch Casino & Resort
MCRI
$2.23B
| $1.14M | ﹤0.01% |
25,980
+7,150
| +38% | +$307K |
|
2480
Altisource Portfolio Solutions
ASPS
$65M
| $1.14M | ﹤0.01% |
6,022
+1,263
| +27% | +$245K |
|
2481
PUT
Vornado Realty Trust
VNO
$7.27B
| $1.14M | ﹤0.01% |
+16,900
| New | +$1.13M |
|
2482
PUT
MidCap Financial Investment
MFIC
$794M
| $1.14M | ﹤0.01% |
+75,000
| New | +$1.13M |
|
2483
ServiceNow
NOW
$130B
| $1.14M | ﹤0.01% |
23,050
-1,920
| -8% | -$84.4K |
|
|
RESI
2484
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.14M | ﹤0.01% |
122,486
+65,038
| +113% | +$678K |
|
2485
MYR Group
MYRG
$4.87B
| $1.13M | ﹤0.01% |
32,651
-11,252
| -26% | -$366K |
|
2486
CALL
AptarGroup
ATR
$8.6B
| $1.13M | ﹤0.01% |
10,600
-10,500
| -50% | -$1.05M |
|
2487
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$281M
| $1.13M | ﹤0.01% |
12
| – | – |
|
2488
Kemper
KMPR
$1.67B
| $1.13M | ﹤0.01% |
14,786
-22,748
| -61% | -$1.74M |
|
|
ENDP
2489
CALL
DELISTED
Endo International plc
ENDP
| $1.12M | ﹤0.01% |
140,000
| – | – |
|
|
ICD
2490
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.12M | ﹤0.01% |
20,266
+2,927
| +17% | +$190K |
|
2491
PUT
Autodesk
ADSK
$53.8B
| $1.12M | ﹤0.01% |
7,200
-2,800
| -28% | -$419K |
|
2492
Evertec
EVTC
$1.78B
| $1.12M | ﹤0.01% |
40,344
-9,121
| -18% | -$258K |
|
2493
CALL
Cencora
COR
$62.6B
| $1.12M | ﹤0.01% |
14,100
+4,100
| +41% | +$329K |
|
2494
PUT
Genuine Parts
GPC
$19.2B
| $1.12M | ﹤0.01% |
10,000
| – | – |
|
|
LM
2495
DELISTED
Legg Mason, Inc.
LM
| $1.12M | ﹤0.01% |
40,921
+17,686
| +76% | +$507K |
|
2496
Orthofix Medical
OFIX
$397M
| $1.12M | ﹤0.01% |
19,833
+1,562
| +9% | +$87.7K |
|
2497
CoStar Group
CSGP
$13B
| $1.12M | ﹤0.01% |
23,960
-71,440
| -75% | -$2.95M |
|
|
RFP
2498
DELISTED
Resolute Forest Products Inc.
RFP
| $1.11M | ﹤0.01% |
141,149
+20,272
| +17% | +$170K |
|
2499
PUT
Eagle Materials
EXP
$6.14B
| $1.11M | ﹤0.01% |
13,200
-3,700
| -22% | -$267K |
|
|
TTM
2500
CALL
DELISTED
Tata Motors Limited
TTM
| $1.11M | ﹤0.01% |
88,600
+50,000
| +130% | +$625K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.